Company Filing History:
4 out of 1,974 
4 out of 257 
Years Active: 2023-2025
Title: Narimon Honarpour: Innovator in Cardiac Treatment
Introduction
Narimon Honarpour is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of cardiac treatment, holding a total of 4 patents. His innovative approaches aim to improve the lives of patients suffering from heart failure.
Latest Patents
Honarpour's latest patents include groundbreaking methods for treating heart failure. One of his notable inventions involves methods of treating heart failure with cardiac sarcomere activators. This patent outlines a process for administering an initial dose of a cardiac sarcomere activator (CSA) and adjusting subsequent doses based on the subject's plasma concentration. Another significant patent focuses on treating heart failure by administering omecamtiv mecarbil, which is effective for patients exhibiting additional features related to their condition.
Career Highlights
Throughout his career, Narimon Honarpour has worked with leading companies in the biotechnology sector. He has been associated with Amgen Inc. and Cytokinetics, Inc., where he has contributed to the development of innovative therapies for heart conditions. His work has been instrumental in advancing treatment options for patients.
Collaborations
Honarpour has collaborated with various professionals in the field, including his coworker Fady Malik. These partnerships have fostered an environment of innovation and have led to the development of effective treatment methodologies.
Conclusion
Narimon Honarpour's contributions to cardiac treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative methods continue to pave the way for advancements in the treatment of heart failure.